BOSTON, July 26, 2016 /PRNewswire/ -- The management team of women’s health therapeutics developer Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) (“Juniper” or the “Company”), will hold a conference call on August 4, 2016, to discuss the financial results for the second quarter ended June 30, 2016. The call details are as follows:
Date: | Thursday, August 4, 2016 |
Time: | 8:30 a.m. EDT |
Dial-in numbers: | Toll free: (866) 374-4635 (U.S.), (855) 669-9657 (Canada), or International: (412) 902-4218 |
Webcast (live & archive): | www.juniperpharma.com, under ‘Investors’ or click here |
The teleconference replay will be available at approximately one hour after completion through Thursday, August 11, 2016, at (877) 344-7529 (U.S.), (855) 669-9658 (Canada) or (412) 317-0088 (International). The conference ID for the replay is 10089864.
The archived webcast will be available for one year via the aforementioned URLs.
About Juniper Pharmaceuticals
Juniper Pharmaceuticals, Inc. is focused on developing therapeutics that address unmet medical needs in women’s health. The Company is advancing a pipeline of proprietary product candidates that leverage novel intravaginal drug delivery technologies. These R&D programs are funded in part by cash flows from Crinone® (progesterone gel) and Juniper Pharma Services, which provides high-end fee-for-service pharmaceutical development, analytical characterization, and clinical trials manufacturing for clients. Please visit www.juniperpharma.com for more information.
Juniper Pharmaceuticals is a trademark of Juniper Pharmaceuticals, Inc., in the U.S. and EU.
CRINONE® is a registered trademark of Merck KGaA, Darmstadt, Germany, outside the U.S. and of Allergan, Inc. in the U.S.
Contact
Amy Raskopf
Director, Corporate Communications, Juniper Pharmaceuticals, Inc.
(917) 673-5775 / ir@juniperpharma.com
To receive Juniper’s press releases, SEC filings or calendar alerts by email click here.
Follow us on LinkedIn
Source: Juniper Pharmaceuticals, Inc.
Logo - http://photos.prnewswire.com/prnh/20150527/218998LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/juniper-pharmaceuticals-to-report-second-quarter-2016-results-on-august-4-2016-300302698.html
SOURCE Juniper Pharmaceuticals, Inc.
